ArticleNPJ Parkinson's disease2026

Inhibition of de novo ceramide synthesis mitigates alpha-synuclein pathology in a Parkinson's disease mouse model.

Eunkyung Lee et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.